HCA Healthcare, Inc. $HCA Holdings Boosted by Strs Ohio

Strs Ohio lifted its stake in HCA Healthcare, Inc. (NYSE:HCA) by 2.0% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 79,038 shares of the company’s stock after purchasing an additional 1,582 shares during the quarter. Strs Ohio’s holdings in HCA Healthcare were worth $30,279,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently added to or reduced their stakes in the company. Cheviot Value Management LLC acquired a new position in HCA Healthcare in the 1st quarter valued at approximately $26,000. Saudi Central Bank bought a new stake in HCA Healthcare in the first quarter worth approximately $26,000. WPG Advisers LLC bought a new stake in HCA Healthcare in the first quarter worth approximately $27,000. Ameriflex Group Inc. bought a new stake in HCA Healthcare in the second quarter worth approximately $27,000. Finally, Chung Wu Investment Group LLC bought a new stake in HCA Healthcare in the second quarter worth approximately $27,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Stock Performance

Shares of NYSE HCA opened at $466.44 on Friday. The firm has a 50 day moving average price of $420.00 and a 200 day moving average price of $385.66. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $478.19. The stock has a market cap of $109.14 billion, a P/E ratio of 18.03, a P/E/G ratio of 1.38 and a beta of 1.40.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Friday, October 24th. The company reported $6.96 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $5.64 by $1.32. The business had revenue of $19.16 billion during the quarter, compared to analysts’ expectations of $18.55 billion. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.HCA Healthcare’s revenue for the quarter was up 9.6% compared to the same quarter last year. During the same period in the prior year, the business earned $4.90 EPS. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. Analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, December 29th. Stockholders of record on Monday, December 15th will be issued a $0.72 dividend. This represents a $2.88 annualized dividend and a dividend yield of 0.6%. The ex-dividend date is Monday, December 15th. HCA Healthcare’s dividend payout ratio is 11.13%.

Insider Buying and Selling at HCA Healthcare

In other news, EVP Michael S. Cuffe sold 3,836 shares of the business’s stock in a transaction on Monday, September 8th. The shares were sold at an average price of $418.84, for a total value of $1,606,670.24. Following the sale, the executive vice president owned 31,503 shares of the company’s stock, valued at $13,194,716.52. The trade was a 10.85% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 1.30% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on HCA shares. Royal Bank Of Canada upped their price objective on shares of HCA Healthcare from $449.00 to $482.00 and gave the stock an “outperform” rating in a report on Monday. TD Cowen increased their price target on shares of HCA Healthcare from $380.00 to $490.00 and gave the company a “buy” rating in a report on Monday. Barclays increased their price target on shares of HCA Healthcare from $445.00 to $494.00 and gave the company an “overweight” rating in a report on Monday. Raymond James Financial set a $525.00 price target on shares of HCA Healthcare in a report on Monday. Finally, JPMorgan Chase & Co. increased their price objective on shares of HCA Healthcare from $360.00 to $370.00 and gave the company a “neutral” rating in a research note on Monday, August 4th. Fourteen research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $473.53.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.